Fulgent Genetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FLGT and other ETFs, options, and stocks.

About FLGT

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions.

CEO

Ming Hsieh

CEOMing Hsieh

Employees

1,313

Employees1,313

Headquarters

El Monte, California

HeadquartersEl Monte, California

Founded

2016

Founded2016

Employees

1,313

Employees1,313

FLGT Key Statistics

Market cap

729.75M

Market cap729.75M

Price-Earnings ratio

-14.23

Price-Earnings ratio-14.23

Dividend yield

—

Dividend yield—

Average volume

196.58K

Average volume196.58K

High today

$23.86

High today$23.86

Low today

$23.46

Low today$23.46

Open price

$23.66

Open price$23.66

Volume

111.77K

Volume111.77K

52 Week high

$24.64

52 Week high$24.64

52 Week low

$14.57

52 Week low$14.57

FLGT News

TipRanks 6d

Fulgent Genetics Presents Promising Phase 2 Trial Data

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 6d

Fulgent Genetics announces preliminary data from Phase 2 study of FID-007

Fulgent Genetics (FLGT) announced preliminary clinical data as of September 25, the preliminary data cutoff from its ongoing phase 2 clinical trial investigatin...

People also own

Based on the portfolios of people who own FLGT. This list is generated using Robinhood data, and it’s not a recommendation.